Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:13 PM
Ignite Modification Date:
2025-12-24 @ 2:13 PM
NCT ID:
NCT00659295
Eligibility Criteria:
Inclusion Criteria:
* Age according to approved label in each country and physician discretion
* Type 1 or 2 diabetes
* Recently started treatment with insulin detemir at the discretion of the investigator. Before initiation of insulin detemir they should not have been treated with insulin
* Selection at the discretion of the physician
Exclusion Criteria:
* Current treatment with Levemir® (insulin detemir)
* Previously enrolled in the study
* Hypersensitivity to Levemir® (insulin detemir)
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00659295
Study Brief:
Protocol Section:
NCT00659295